Evidence map›Paper›PMID 28135014›Full record

ArticleJournal of orthopaedic research : official publication of the Orthopaedic Research Society2017

Biocompatibility, bone healing, and safety evaluation in rabbits with an IlluminOss bone stabilization system.

Amanda L McSweeney, Brett G Zani, Rose Baird, James R L Stanley, Alison Hayward, Peter M Markham, Gregory A Kopia, Elazer R Edelman, Robert Rabiner

Open access · bronzeAbstract readEvaluation Study
In one paragraph

Article in Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Amanda L McSweeneyConcord Biomedical Sciences and Emerging Technologies, 500 Shire Way, Lexington, Massachusetts 02421.
Brett G ZaniConcord Biomedical Sciences and Emerging Technologies, 500 Shire Way, Lexington, Massachusetts 02421.
Rose BairdConcord Biomedical Sciences and Emerging Technologies, 500 Shire Way, Lexington, Massachusetts 02421.
James R L StanleyConcord Biomedical Sciences and Emerging Technologies, 500 Shire Way, Lexington, Massachusetts 02421.
Alison HaywardConcord Biomedical Sciences and Emerging Technologies, 500 Shire Way, Lexington, Massachusetts 02421.
Peter M MarkhamConcord Biomedical Sciences and Emerging Technologies, 500 Shire Way, Lexington, Massachusetts 02421.
Gregory A KopiaKopia Consulting, 61-4D Taurus Drive Hillsborough, Hillsborough, New Jersey 08844.
Elazer R EdelmanInstitute for Medical and Engineering Science, Massachusetts Institute of Technology, E25, 45 Carleton Street, Cambridge, Massachusetts 02139.
Robert RabinerIlluminOss Medical Inc., 993 Waterman Avenue, East Providence, Rhode Island 02914.
Concord Consortium · USMassachusetts Institute of Technology · US

Funding

Vascular Drug Delivery - Supplement for EquipmentR01GM049039 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI EDELMAN, ELAZER R · 1994 to 2019
$8.9M
NIGMS NIH HHS R01 GM049039
6 · The paper itself

Abstract

Bone healing, biocompatibility, and safety employing the IlluminOss System (IS), comprised of an inflatable balloon filled with photopolymerizable liquid monomer, was evaluated in New Zealand white rabbits. Successful bone healing and callus remodeling over 6 months was demonstrated radiologically and histologically with IS implants in fenestrated femoral cortices. Biocompatibility was demonstrated with IS implants in brushed, flushed femoral intramedullary spaces, eliciting no adverse, local, or systemic responses and with similar biocompatibility to K-wires in contralateral femurs up to 1 year post-implant. Lastly simulated clinical failures demonstrated the safety of IS implants up to 1 year in the presence of liquid or polymerized polymer within the intramedullary space. Polymerized material displayed cortical bone and vasculature effects comparable to mechanical disruption of the endosteum. In the clinically unlikely scenario with no remediation or polymerization, a high dose monomer injection resulted in marked necrosis of cortical bone, as well as associated vasculature, endosteum, and bone marrow. Overall, when polymerized and hardened within bone intramedullary spaces, this light curable monomer system may provide a safe and effective method for fracture stabilization. © 2017 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 35:2181-2190, 2017.

Indexed as

AnimalsFemaleFemoral FracturesFracture Fixation, InternalFracture HealingMaterials TestingMinimally Invasive Surgical ProceduresRabbitsbiocompatibilityfracture stabilizationintramedullarylight-curablepolymer

Identifiers

PMID28135014
PMCPMC5534392
OpenAlexW2580114294

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.